What is the appropriate oral aciclovir 200 mg dosing regimen?

Oral Aciclovir 200mg Dosing Regimens

The appropriate oral aciclovir 200mg dosing regimen depends on the indication: for initial genital herpes, give 200mg five times daily for 10 days; for recurrent genital herpes intermittent therapy, give 200mg five times daily for 5 days; and for chronic suppressive therapy, give 200mg 3-5 times daily (typically starting at 400mg twice daily and adjusting down). 1

Treatment of Initial Genital Herpes

For first-episode genital herpes, the FDA-approved regimen is 200mg every 4 hours, 5 times daily for 10 days 1. This longer duration (10 days vs 5 days for recurrences) is critical because initial episodes are typically more severe and prolonged. Guidelines from multiple sources confirm this approach, with aciclovir 200mg 5 times daily for 5-10 days being effective 2, 3.

• Initiate treatment as soon as possible after diagnosis
• The 5-times-daily schedule requires dosing approximately every 4 hours while awake
• This regimen reduces duration of symptoms and viral shedding

Intermittent Therapy for Recurrent Episodes

For recurrent genital herpes, use 200mg every 4 hours, 5 times daily for 5 days 1. The key to success is patient-initiated early treatment:

• Start at the earliest sign or symptom (prodrome) of recurrence 1
• Treatment initiated during prodrome may abort the episode in some patients 2
• The shorter 5-day course (vs 10 days for initial episodes) is sufficient for recurrences
• Studies show mixed results when treatment is delayed, emphasizing the importance of early initiation 4

Chronic Suppressive Therapy

For patients with frequent recurrences, suppressive therapy is indicated. The FDA-approved regimen is 400mg twice daily for up to 12 months 1, though alternative regimens include 200mg 3-5 times daily:

• Starting dose: 200mg four times daily appears most effective based on comparative studies 5
• 400mg twice daily may suffice and improves compliance 1
• Studies show 200mg four times daily had statistically significantly longer time to first recurrence compared to 400mg twice daily (p<0.02) 5
• As total daily dose decreases, time to first recurrence shortens 5

Suppressive Therapy Management

• Re-evaluate after 1 year to assess need for continuation 1
• Reduce total daily dose as far as possible while maintaining efficacy 2
• Interrupt treatment yearly to determine ongoing need 2
• Long-term suppression is safe with no important side effects reported 5
• Frequency of recurrences after stopping treatment is significantly less than pre-treatment (0.71 vs 1.1 per 28 days, p=0.001) 5

Non-Genital Herpes Simplex Suppression

For recurrent non-genital HSV infection (e.g., herpes labialis), 200mg four times daily effectively suppresses recurrences 6. Only 2 of 11 patients experienced recurrence during treatment vs 9 on placebo (p=0.016) 6.

Special Populations

Pregnancy

• For first episode during pregnancy: 200mg 5 times daily for 5-10 days 3
• For recurrent herpes during pregnancy: 200mg 5 times daily 3
• Prophylaxis from 36 weeks until delivery: standard suppressive dosing 3
• Pharmacokinetics in late pregnancy are similar to non-pregnant adults 7

Renal Impairment

Critical adjustment required 1:

• CrCl >10 mL/min: 200mg every 4 hours (no adjustment)
• CrCl 0-10 mL/min: 200mg every 12 hours
• Hemodialysis: Administer additional dose after each dialysis

Common Pitfalls

• Delayed initiation: Efficacy drops dramatically when treatment starts >24 hours after symptom onset
• Inadequate dosing frequency: The 5-times-daily regimen requires strict adherence; missing doses reduces efficacy
• Premature discontinuation of suppressive therapy: Some patients stop after a few months without recurrence, but yearly evaluation is recommended
• Forgetting renal adjustment: Failure to adjust for renal impairment increases risk of neurotoxicity
• Not counseling on transmission: Aciclovir is not a cure and does not prevent transmission; patients need counseling on safe practices 1

Key Clinical Points

• Maintain adequate hydration during therapy to reduce nephrotoxicity risk 1
• Aciclovir does not prevent asymptomatic viral shedding or transmission 1
• For herpes zoster, higher doses (800mg 5 times daily) are required, not 200mg 1
• The 200mg dose is insufficient for immunocompromised patients who typically require higher doses or IV therapy 2